Since 2017, the FDA approved more than two dozen new therapies with roots at Penn Medicine almost half of which are first-in-class for their indications.
Johns Hopkins Medicine scientists say their 20-year study of more than 200 people with premature aging syndromes caused by abnormally short telomeres, or shortened repetitive DNA sequences at the ends of chromosomes, may upend long-held scientific do
Breakthrough Study Shows Promise for mRNA Cancer Vaccines propakistani.pk - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from propakistani.pk Daily Mail and Mail on Sunday newspapers.
For decades, cancer vaccines have been tested, though no real promising results have emerged. However, results of a new clinical trial involving melanoma patients are giving experts a fresh boost of optimism.